| Factors | All subjects | NC impaired | NC unimpaired | P value |
---|---|---|---|---|---|
( n  = 107) | ( n  = 58) | ( n  = 49) | |||
Plasma | IGF1 (mean ± SD, ng/ml) | 192.5 ± 55.3 | 186.0 ± 63.28 | 200.1 ± 43.7 | 0.127 |
IGF2 (mean ± SD, ng/ml) | 703.3 ± 165.2 | 686.1 ± 170.5 | 723.3 ± 158.3 | 0.520 | |
log IGFBP1 (mean ± SD, ng/ml)a | 1.43 ± 0.74 | 1.45 ± 0.85 | 1.40 ± 0.59 | 0.797 | |
IGFBP2 - median (IQR) | 33.97 | 38.59 | 26.00 | 0.346 | |
(14.44 to 51.76) | (16.13 to 47.72) | (6.54 to 54.39) | |||
log IGF2R (mean ± SD, ng/ml)a | 4.51 ± 0.88 | 4.47 ± 0.97 | 4.56 ± 0.77 | 0.716 | |
CSF | IGF1 - median (IQR) | 1.11 (0.92 to 1.48) | 1.11 (0.88 to 1.48) | 1.13 (0.92 to 1.51) | 0.821 |
log IGF2 (mean ± SD, ng/ml)a | 3.70 ± 0.17 | 3.72 ± 0.17 | 3.68 ± 0.17 | 0.345 | |
IGFBP1 - median (IQR) | 0.48 (0.35 to 0.77) | 0.50 (0.37 to 0.75) | 0.47 (0.33 to 1.59) | 0.880 | |
log IGFBP2 (mean ± SD, ng/ml)a | 4.35 ± 0.37 | 4.35 ± 0.32 | 4.36 ± 0.41 | 0.986 | |
IGF2R0.5 (mean ± SD, ng/ml)b | 2.56 ± 0.84 | 2.51 ± 0.87 | 2.62 ± 0.80 | 0.498 |